title: Identification of the immunoproteasome as a novel regulator of skeletal muscle differentiation.
abstract: While many of the molecular details of myogenesis have been investigated extensively, the function of immunoproteasomes (i-proteasomes) in myogenic differentiation remains unknown. We show here that the mRNA of i-proteasome subunits, the protein levels of constitutive and inducible proteasome subunits, and the proteolytic activities of the 20S and 26S proteasomes were significantly upregulated during differentiation of skeletal muscle C2C12 cells. Knockdown of the i-proteasome catalytic subunit PSMB9 by short hairpin RNA (shRNA) decreased the expression of both PSMB9 and PSMB8 without affecting other catalytic subunits of the proteasome. PSMB9 knockdown and the use of i-proteasome-specific inhibitors both decreased 26S proteasome activities and prevented C2C12 differentiation. Inhibition of the i-proteasome also impaired human skeletal myoblast differentiation. Suppression of the i-proteasome increased protein oxidation, and these oxidized proteins were found to be more susceptible to degradation by exogenous i-proteasomes. Downregulation of the i-proteasome also increased proapoptotic proteins, including Bax, as well as cleaved caspase 3, cleaved caspase 9, and cleaved poly(ADP-ribose) polymerase (PARP), suggesting that impaired differentiation is likely to occur because of significantly increased apoptosis. These results demonstrate for the first time that i-proteasomes, independent of constitutive proteasomes, are critical for skeletal muscle differentiation of mouse C2C12 cells.
authors.affiliation: Department of Neurobiology, Physiology, and Behavior, University of California, Davis, California, USA.
authors.forename: Ziyou
authors.initials: Z
authors.lastname: Cui
authors.forename: Soyun Michelle
authors.initials: SM
authors.lastname: Hwang
authors.forename: Aldrin V
authors.initials: AV
authors.lastname: Gomes
mesh_terms: D000818:Animals; D017209:Apoptosis; D015153:Blotting, Western; D002154:Calpain / Q000378:metabolism; D020169:Caspases / Q000378:metabolism; D056668:Cathepsin L / Q000378:metabolism; D002454:Cell Differentiation; D002460:Cell Line; D003546:Cysteine Endopeptidases / Q000235:genetics / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D015870:Gene Expression; D051379:Mice; D008856:Microscopy, Fluorescence; D018482:Muscle, Skeletal / Q000166:cytology / Q000378:metabolism*; D032446:Myoblasts / Q000166:cytology / Q000378:metabolism*; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism; D046988:Proteasome Endopeptidase Complex / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D034622:RNA Interference; D017382:Reactive Oxygen Species / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D051028:bcl-2-Associated X Protein / Q000378:metabolism
chemical_list: D017382:Reactive Oxygen Species; D051028:bcl-2-Associated X Protein; C071313:LMP-2 protein; D011065:Poly(ADP-ribose) Polymerases; D002154:Calpain; D020169:Caspases; D003546:Cysteine Endopeptidases; D056668:Cathepsin L; C077436:LMP7 protein; D046988:Proteasome Endopeptidase Complex; C061553:ATP dependent 26S protease